A detailed history of Wellington Management Group LLP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 11,242,144 shares of RCKT stock, worth $131 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
11,242,144
Previous 9,155,720 22.79%
Holding current value
$131 Million
Previous $197 Million 5.34%
% of portfolio
0.04%
Previous 0.04%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$17.6 - $25.88 $36.7 Million - $54 Million
2,086,424 Added 22.79%
11,242,144 $208 Million
Q2 2024

Aug 13, 2024

SELL
$20.66 - $26.72 $7,830 - $10,126
-379 Reduced -0.0%
9,155,720 $197 Million
Q1 2024

May 15, 2024

BUY
$26.16 - $30.74 $240 Million - $281 Million
9,156,099 New
9,156,099 $247 Million
Q4 2023

Feb 12, 2024

BUY
$16.78 - $31.94 $138 Million - $262 Million
8,197,546 New
8,197,546 $246 Million
Q3 2023

Nov 14, 2023

BUY
$15.07 - $24.05 $43.4 Million - $69.3 Million
2,880,373 Added 56.01%
8,022,830 $164 Million
Q2 2023

Aug 14, 2023

BUY
$16.59 - $23.6 $17.2 Million - $24.4 Million
1,034,529 Added 25.18%
5,142,457 $102 Million
Q1 2023

May 12, 2023

BUY
$15.79 - $22.6 $9.49 Million - $13.6 Million
600,911 Added 17.13%
4,107,928 $70.4 Million
Q4 2022

Feb 13, 2023

BUY
$15.5 - $22.76 $443,377 - $651,049
28,605 Added 0.82%
3,507,017 $68.6 Million
Q3 2022

Nov 14, 2022

BUY
$12.37 - $18.41 $894,140 - $1.33 Million
72,283 Added 2.12%
3,478,412 $55.5 Million
Q2 2022

Aug 15, 2022

SELL
$7.96 - $16.64 $529,435 - $1.11 Million
-66,512 Reduced 1.92%
3,406,129 $46.9 Million
Q1 2022

May 16, 2022

SELL
$13.16 - $23.68 $240,012 - $431,875
-18,238 Reduced 0.52%
3,472,641 $55.1 Million
Q4 2021

Feb 11, 2022

BUY
$21.52 - $36.02 $3.11 Million - $5.21 Million
144,648 Added 4.32%
3,490,879 $76.2 Million
Q3 2021

Nov 15, 2021

SELL
$27.42 - $48.97 $23.9 Million - $42.7 Million
-871,744 Reduced 20.67%
3,346,231 $100 Million
Q2 2021

Aug 16, 2021

BUY
$39.41 - $47.25 $22 Million - $26.4 Million
558,898 Added 15.27%
4,217,975 $187 Million
Q1 2021

May 17, 2021

BUY
$43.34 - $65.91 $42.4 Million - $64.4 Million
977,556 Added 36.46%
3,659,077 $162 Million
Q4 2020

Feb 12, 2021

BUY
$23.3 - $59.57 $23.3 Million - $59.6 Million
999,916 Added 59.46%
2,681,521 $147 Million
Q3 2020

Nov 16, 2020

SELL
$20.5 - $28.59 $151,392 - $211,137
-7,385 Reduced 0.44%
1,681,605 $38.4 Million
Q2 2020

Aug 14, 2020

BUY
$13.32 - $22.61 $126,673 - $215,021
9,510 Added 0.57%
1,688,990 $35.4 Million
Q1 2020

May 14, 2020

SELL
$9.71 - $25.11 $836,662 - $2.16 Million
-86,165 Reduced 4.88%
1,679,480 $23.4 Million
Q4 2019

Feb 11, 2020

BUY
$11.07 - $24.23 $19.5 Million - $42.8 Million
1,765,645 New
1,765,645 $40.2 Million

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $884M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.